Stock Picks
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What time is the walk down sir? Trying to buy more at $2.15
PRED got the guy who ran GE Healthcare & Metronic.
GE Healthcare had $19 Billion in revenue last year.
Medtronic plc is the world's largest medical device company that generates $30 Billion+ in revenue per year.
This guy is a huge get for $PRED!
https://www.marketwatch.com/press-release/predictive-technology-group-names-biologic-industry-leader-jeff-acuff-as-chief-commercial-officer-of-predictive-biotech-2019-08-23?siteid=nbsh
Great $PRED News! WOW...this keeps getting better.
Mr. Acuff has more than 25 years of commercial and leadership experience for GE Healthcare & Medtronic!
https://www.marketwatch.com/press-release/predictive-technology-group-names-biologic-industry-leader-jeff-acuff-as-chief-commercial-officer-of-predictive-biotech-2019-08-23?siteid=nbsh
Ya baby! Great news! They are about to drop some bombs at these conferences in front of a bunch of rich people. There’s about to be a rush of buying here.
$40 price? That’s a bit low. My first batch is for sale at $125. It should hit that within 3 years.
He seems to think they are still in business, despite the fact that everyone left 2 years ago.
$PRED News...WOW! This just keeps getting better.
"Predictive's existing library of over 300,000 DNA samples..."
"we reached this new collection milestone of 2,500 samples very rapidly and we continue to build on our database."
https://www.marketwatch.com/press-release/predictive-technology-group-accelerates-research-sample-collections-to-support-development-of-personalized-molecular-diagnostics-and-clinical-therapies-2019-08-20?siteid=nbsh
YRIV is a Chinese company with $3 million in sales per year.
PRED is a US company currently with an estimated $60 million in sales per year and if rumors are true, $2-$3 Billion projected in sales next year.
Revenue will win out here.
It depends on the institution. Most aren’t allowed to by pink sheet companies and can start buying as soon as it’s on NASDAQ, no matter what the price is. Others may have a clause that they can’t buy under $5 without board approval.
Thomas stated on one of his post on Sunday, "Bradley Robinson, PRED's CEO was not interviewing with CNBC the day he visited with NASDAQ officials, there were other meetings with media and of institutional financial importance."
One could assume that there is large institutional interest getting ready to buy.
You should definitely sell before it goes up 2000%
Shorts run for cover
The date on that website updates to whatever the current date is.
This is a PR from 2017, that never happened:
https://www.globenewswire.com/news-release/2017/04/19/1244649/0/en/Graecrest-Energy-Solutions-Reaffirms-Its-Funding-Commitment-to-Dominovas-Energy.html
Go back 2 years ago and read what happened to the demo Rubicon. They never got it to work. Please stop trying to trick people here.
There is no new team or no Rubicon. Don’t you think the company would announce it if there was?
Absolutely CT. It’s way bigger than chat boards. They will short at $10, short hard, cover at $7. Then let it run to $15, short hard, cover at $11. They know what they are doing. Let’s see if they can beat institutional money. Worldwide revenues will always win out. I like Canada...mostly Drake. "He has more slaps than The Beatles."
Pretty simple. This ticker is a retirement stock. Straight up zip code changer in the next 3 years.
Stem cells are about to eradicate diseases and chronic pain, etc. You are making a bet on one thing. The fact that the FDA will approve or already has approved what PRED & Thermo are rolling out worldwide.
The stem cell industry will be $297 Billion by 2022.
If PRED/Thermo gets 5% of the industry, it’s a $150 stock with ease.
I would not be surprised if they spin out some of the divisions here.
Place your bets. Get ready for a short squeeze. Very soon. Tell your girl she’s getting a new crib if she acts right. RIP Russian Mafia.
https://www.marketwatch.com/press-release/stem-cells-market-size-is-projected-to-be-around-us-297-billion-by-2022-2018-06-19
These hit pieces keep getting weaker. The guy is no longer listed under management and this is from March 2018. If only they knew who the current sales team is and how many countries they distribute in. Last week to accumulate before take off?
Just imagine everyone who ever goes in for chronic pain treatment, having to take this test. I’d imagine with Thermos help, they will try to go worldwide with this.
Huge news! Commercially launch of PGxPLUS+ to pain clinics. This will probably be multi-billion dollar per year revenue for $PRED. Chronic Pain Treatment Market to Reach $105.9 Billion by 2024!!!
https://yesinternational.com/predictive-technology-group-announces-launch-of-pgxplus-pharmacogenomic-test-and-reaches-clinical-study-enrollment-milestone/
https://www.globenewswire.com/news-release/2019/01/07/1680944/0/en/Chronic-Pain-Treatment-Market-to-Reach-105-9-Billion-by-2024-P-S-Intelligence.html
They were going to make a Demo Fuel Cell 3 years ago, but it never happened. All the employees left. So you can stop with all this pumping bs.
LOL. You seem to think this company is still in business.
Great addition to the team!
https://www.linkedin.com/in/bob-wassman-0523526
Dr. Wassman brings 35 years of genetics diagnostic and personalized medicine experience, and significant expertise to lead the cytogenetics section of Predictive Laboratories!
Yep, many were warned here. RIP
Thanks stockguru...this is about the best paragraph I’ve seen written on PRED and we are just getting started:
“So now we have pred involved in endometriosis testing and treatments (multi billion $ field) preeclampsia (multi billion $ area) about to run a fda trail with IQvia of treatment of knee pain. About to do something on scoliosis (stem cell based) generating significant growing revenues, launched cellsure (another multi billion $ field) entered into a deal with ThermoFisher, has a who’s who of big pharma involved in management and board of directors, has the top legal company in the world Wilson Sonsini dealing with everything, with much more to come.”
Damn! They are building a absolute mega company. I’m starting to believe those $300+ projections
It’s not needed. Nasdaq will grant conditional listing next week and PRED will be allowed to come out with partnership & revenue projections. Price will gap up to $12 with ease and auto uplisted.
Nasdaq knows what we have. They could care less about the current price.
LOL. From 2018 and no wrong doing
Man this is going to slingshot to new highs with any type of good news! I was happy to grab some more shares today near the lows.
Who is “they”
They know they have about a week before uplist (per 60-day timeframe).
So this is going to be a great week for them to cover their short positions and a great week for me to accumulate more shares.
It’s not exactly a quiet period...They are allowed to come out with PRs, but the PRs can’t have new revenue deals or future revenue projections. This would change financials on NASDAQ application.
Thanks stockguru! People have no clue how much this is about to be worth. $30 Billion matketcap is pretty conservative.
Glitch has been fixed now. I’m seeing 2.57 bid
Why would get out now? It’s about to be a MJ explosion in Asia. Rafa will be the main benefactor.
I’m just going off past financials. It may already be at $600k per day. That means it would probably be more like $2 million in sales per day next year.
Ya, I wouldn’t be too worried about a company that is currently doing around $150k per day in sales and will do at least $1 million per day in sales next year.
PRED's partner Thermo Fisher Scientific is currently in 45 countries by my count! Huge Worldwide Market for PRED to Expand in.
UNITED STATES AND CANADA (26,000 employees across 400 Offices)
https://jobs.thermofisher.com/page/show/Locations-North-America
-United States
-Canada
EUROPE | MIDDLE EAST | AFRICA (20,000 employees across 156 Offices)
https://jobs.thermofisher.com/page/show/Locations-EMEA
-Austria
-Belgium
-Czech Republic
-Denmark
-Finland
-France
-Germany
-Greece
-Hungary
-Ireland
-Israel
-Italy
-Lithuania
-Netherlands
-Norway
-Poland
-Portugal
-Russia
-South Africa
-Spain
-Sweden
-Switzerland
-United Arab Emerates
-United Kingdom
THERMO FISHER SCIENTIFIC - APAC REGION (10,000 employees across 16 countries)
https://jobs.thermofisher.com/page/show/Locations-APAC
-Australia
-China
-India
-Japan
-Malaysia
-New Zealand
-Singapore
-South Korea
-Thailand
-Vietnam
LATIN AMERICA (2,000 employees)
https://jobs.thermofisher.com/page/show/Locations-Latin-America
-Brazil
-Mexico
-Argentina
-Chile
-Colombia
-Costa Rica
-Peru
-Venezuela
Other Countries with Field Agents (Map at the Bottom)
https://jobs.thermofisher.com/
-Uzbekistan
You’ve got bad info. Read the PR from today:
Investor Contact
LHA Investor Relations
Jody Cain jcain@lhai.com
Kevin Mc Cabe kmccabe@lhai.com
310-691-7100
Awesome! Great to hear from a someone using Predictive’s Regenerative medicine tissue products. I heard they are expanding the sales reps nationwide and then probably to many countries worldwide.
Where are you located? Tying to get a idea of their current sales rep coverage.